Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Both hold potential in different domains: Bitcoin as peer-to-peer money and blockchain as a platform for diverse, programmable applications.
28,588 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
A clear spark lit up Rivian stock as the R2 SUV launch was confirmed. This piece breaks down what it means for the st...
Pfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
If you have $3,000 ready to invest, you can build a focused trio of growth, income, and stability. This guide shows t...
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Alphabet’s latest AI and cloud initiatives are fueling optimism, even as investors weigh whether Wall Street is under...
Zillow has fallen hard, but the question for investors is whether a comeback is plausible. This guide breaks down the...
A tiny stock has surged 680% in a year, grabbing headlines and investor attention. This guide breaks down what’s driv...
Oracle shares hover near $144 as AI infrastructure demand meets cash-flow headwinds. A rising backlog and lofty reven...
As markets swing and newcomers crowd the fintech scene, 2026 could determine whether Robinhood finally builds a durab...
As rates trend higher, investors worry about income and growth. This article explores a dividend ETF designed to weat...
Marvell Technology climbs as Wall Street shifts to a more favorable view after closing the XConn deal, with price tar...